Multiple Myeloma (MM) Terminated Phase 1 / 2 Trials for Cefotaxime (DB00493)

Also known as: MULTIPLE MYELOMA (MM) / Multiple myeloma / Myeloma, Multiple / Multiple Myelomas / Multiple Myeloma(MM) / Plasma cell myelomas / Myelomatosis multiple / Peripheral plasma cell myeloma / Myelomatosis / Multiple myeloma myelomatosis / Plasma cell myeloma / Myeloma / Multiple myeloma with failed remission

IndicationStatusPhase
DBCOND0040908 (Multiple Myeloma (MM))Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02206425Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma PatientsTreatment